Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/37996
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDagorn, Pascale Gluais-
dc.contributor.authorBuchholz, Bjoern-
dc.contributor.authorBange, Hester-
dc.contributor.authorBLOCKKEN, Laura-
dc.contributor.authorMoller, David E.-
dc.contributor.authorHallakou-Bozec, Sophie-
dc.date.accessioned2022-09-07T08:51:37Z-
dc.date.available2022-09-07T08:51:37Z-
dc.date.issued2022-
dc.date.submitted2022-08-16T12:51:00Z-
dc.identifier.citationNEPHROLOGY DIALYSIS TRANSPLANTATION, 37 (Art N° MO019)-
dc.identifier.urihttp://hdl.handle.net/1942/37996-
dc.language.isoen-
dc.publisherOXFORD UNIV PRESS-
dc.rightsThe Author(s) 2022. Published by Oxford University Press on behalf of the ERA. This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)-
dc.titlePreclinical efficacy of direct AMPK activation with a novel small molecule -PXL770- for the treatment of autosomal dominant polycystic kidney disease-
dc.typeJournal Contribution-
dc.identifier.spageI9-
dc.identifier.volume37-
local.bibliographicCitation.jcatM-
local.publisher.placeGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
local.bibliographicCitation.artnrMO019-
local.classdsPublValOverrule/no_publishing_delay-
dc.identifier.isi000813350700020-
local.provider.typewosris-
local.description.affiliation[Dagorn, Pascale Gluais; Moller, David E.; Hallakou-Bozec, Sophie] Poxel SA, Lyon, France.-
local.description.affiliation[Buchholz, Bjoern] Univ Hosp Erlangen, Erlangen, Germany.-
local.description.affiliation[Bange, Hester] Crown Biosci Netherlands BV, Amsterdam, Netherlands.-
local.description.affiliation[Blockken, Laura] InnoSer Belgie NV, Diepenbeek, Belgium.-
local.uhasselt.internationalyes-
item.fullcitationDagorn, Pascale Gluais; Buchholz, Bjoern; Bange, Hester; BLOCKKEN, Laura; Moller, David E. & Hallakou-Bozec, Sophie (2022) Preclinical efficacy of direct AMPK activation with a novel small molecule -PXL770- for the treatment of autosomal dominant polycystic kidney disease. In: NEPHROLOGY DIALYSIS TRANSPLANTATION, 37 (Art N° MO019).-
item.fulltextWith Fulltext-
item.contributorDagorn, Pascale Gluais-
item.contributorBuchholz, Bjoern-
item.contributorBange, Hester-
item.contributorBLOCKKEN, Laura-
item.contributorMoller, David E.-
item.contributorHallakou-Bozec, Sophie-
item.accessRightsRestricted Access-
crisitem.journal.issn0931-0509-
crisitem.journal.eissn1460-2385-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
RENAL DEVELOPMENT AND CYSTIC DISEASES.pdf
  Restricted Access		Published version83.71 kBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.